2253-P: Asian Ancestry and Higher Predicted 10-Year Type 2 Diabetes Risk: Greater Insulin Resistance and Lower β-Cell Function
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2253-p ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von ALAWAB ALDULIMY und 2 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction and Objective: Individuals of Asian (ASN) ancestry are at higher risk of type 2 diabetes mellitus (T2DM) than those of European (EUR) ancestry. Insulin resistance and β-cell dysfunction increase the risk of T2DM. However, it is uncertain whether individuals of ASN ancestry have lower β-cell function at a given degree of insulin resistance than those of EUR ancestry.
Methods
We studied 448 individuals without diabetes (125 ASN and 323 EUR). We calculated the 10-year estimated risk of T2DM using the QDiabetes-2018 risk prediction algorithm. We directly measured insulin resistance by steady-state plasma glucose (SSPG) concentration during the Insulin Suppression Test and β-cell function by fasting C-peptide concentration. We stratified individuals by median SSPG concentration into insulin resistant (IR; above median) and insulin sensitive (IS; below median) groups.
Results
The mean ± standard deviation age of participants was 50 ± 10 years, and 58% were women. The 10-year QDiabetes risk was higher in ASN participants than in those of EUR ancestry (13.2 ± 17.3% vs. 8.5 ± 9.9%; P <0.001). SSPG concentration was also higher in ASN participants than in those of EUR ancestry (169 vs. 137 mg/dL; P <0.01, adjusted for age, sex, and BMI). Among all participants, for each 30-unit increase in SSPG concentration, QDiabetes risk increased by 2.4% (P <0.001). In the IR group, SSPG concentration was similar (202 ± 41 vs. 201 ± 41 mg/dL; P = 0.87), but fasting C-peptide concentration was lower (1.99 vs. 2.29 ng/mL; P = 0.02) in ASN participants than in those of EUR ancestry.
Conclusion
Individuals of ASN ancestry have higher 10-year diabetes risk and greater degree of insulin resistance compared to those of EUR ancestry. Among IR individuals, despite a similar degree of insulin resistance, ASN individuals have lower β-cell function than those of EUR ancestry. Evaluation of both insulin resistance and β-cell function in ASN individuals may help address diabetes risk and its reduction through therapies that improve insulin resistance and β-cell function. Disclosure A. Aldulimy: None. F. Abbasi: None. J. Knowles: Consultant; Current; Wave Biosciences, Mammoth. Funding Accelerate Innovation in Diabetes LeVeraging Unique PAthways iN Asians Program (ADVANCE)
Zitieren
APA
ALDULIMY, A., ABBASI, F., & KNOWLES, J. (2026). 2253-P: Asian Ancestry and Higher Predicted 10-Year Type 2 Diabetes Risk: Greater Insulin Resistance and Lower β-Cell Function. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2253-p
Vancouver
ALDULIMY A, ABBASI F, KNOWLES J. 2253-P: Asian Ancestry and Higher Predicted 10-Year Type 2 Diabetes Risk: Greater Insulin Resistance and Lower β-Cell Function. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2253-p
BibTeX
@article{ALDULIMY2026,
author = {ALDULIMY, ALAWAB and ABBASI, FAHIM and KNOWLES, JOSH},
title = {2253-P: Asian Ancestry and Higher Predicted 10-Year Type 2 Diabetes Risk: Greater Insulin Resistance and Lower β-Cell Function},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2253-p}
}
EUVIMED